The DOI matches its Crossref record; 53 of the 59 references it cites were found in a registry or an index.
Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth
Open accessAbstract
Colorectal carcinoma (CRC) is a major cause of morbidity and mortality in Western countries. It has so far been molecularly defined mainly by alterations of the Wnt pathway. We show here for the first time that aberrant activities of the signal transducer and activator of transcription STAT3 actively contribute to this malignancy and, thus, are a potential therapeutic target for CRC. Constitutive STAT3 activity was found to be abundant in dedifferentiated cancer cells and infiltrating lymphocytes of CRC samples, but not in non-neoplastic colon epithelium. Cell lines derived from malignant colorectal tumors lost persistent STAT3 activity in culture. However, implantation of colon carcinoma cells into nude mice resulted in restoration of STAT3 activity, suggesting a role of an extracellular stimulus within the tumor microenvironment as a trigger for STAT activation. STAT3 activity in CRC cells triggered through interleukin-6 or through a constitutively active STAT3 mutant promoted cancer cell multiplication, whereas STAT3 inhibition through a dominant-negative variant impaired IL-6-driven proliferation. Blockade of STAT3 activation in CRC-derived xenograft tumors slowed down their development, arguing for a contribution of STAT3 to colorectal tumor growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 via STAT-3 has been shown to promote tumor cell proliferation in many cancers, including oral squamous cell carcinoma via DNA hypomethylation (31), prostate cancer through androgen receptor activation (32), and colon cancer (33).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [33]
In the citing paper
“Constitutive STAT3 signaling has been implicated in aberrant cell growth and proliferation in many cancers, including head and neck squamous cell carcinoma, colorectal carcinoma, melanoma, glioblastoma multiforme, multiple myeloma, non-small cell lung cancer, and others.58,69–73”
From Critical analysis of the potential for targeting STAT3 in human malignancy (2013) · cites this paper as [69]
Citations
Cites
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323
O’Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,137
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Ory, D., Neugeboren, B. I., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 926
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 863
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 834
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 532
Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., & Yu, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205859 · Cited by 432
Rahaman, S. O., Harbor, P. C., Chernova, O., Barnett, G. H., Vogelbaum, M. A., & Haque, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206047 · Cited by 377
Masuda, M., Suzui, M., Yasumatu, R., Nakashima, T., Kuratomi, Y., Azuma, K., Tomita, K., Komiyama, S., & Weinstein, I. B. (2002) · PubMed · Cited by 376
Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling
Kielman, M. F., Rindapää, M., Gaspar, C., van Poppel, N., Breukel, C., van Leeuwen, S., Taketo, M. M., Roberts, S., Smits, R., & Fodde, R. (2002) · Nature Genetics · doi:10.1038/ng1045 · Cited by 362
Interleukin-6 Is an Autocrine Growth Factor in Human Prostate Cancer
Giri, D., Özen, M., & Ittmann, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63067-2 · Cited by 336
GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
Grady, W. M., & Markowitz, S. D. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103043 · Cited by 323
Real, P. J., Sierra, A., de Juan, A., Segovia, J. C., Lopez-Vega, J. M., & Fernandez-Luna, J. L. (2002) · Oncogene · doi:10.1038/sj.onc.1206004 · Cited by 321
Wnt/Beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis
Kolligs, F. T., Bommer, G. T., & Göke, B. (2002) · Digestion · doi:10.1159/000066755 · Cited by 317
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 313
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
Burke, W. M., Jin, X., Lin, H.-J. L., Huang, M., Liu, R., Reynolds, R. K., & Lin, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204990 · Cited by 271
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Schuringa, J., Wierenga, A., Kruijer, W., & Vellenga, E. (2000) · Blood · doi:10.1182/blood.v95.12.3765 · Cited by 213
Epling‐Burnette, P. K., Zhong, B., Bai, F., Jiang, K., Bailey, R. D., Garcia, R., Jove, R., Djeu, J. Y., Loughran, T. P., & Wei, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7486 · Cited by 183
Beneklı, M., Xia, Z., Donohue, K. A., Ford, L. A., Pixley, L. A., Baer, M. R., Baumann, H., & Wetzler, M. (2002) · Blood · doi:10.1182/blood.v99.1.252 · Cited by 181
Stat3 Controls Cell Movements during Zebrafish Gastrulation
Yamashita, S., Miyagi, C., Carmany-Rampey, A., Shimizu, T., Fujii, R., Schier, A. F., & Hirano, T. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00126-0 · Cited by 178
Schaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 175
Activation of Signal Transducer and Activator of Transcription 3 in Renal Cell Carcinoma:
Horiguchi, A., Oya, M., Shimada, T., Uchida, A., Marumo, K., & Murai, M. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64741-6 · Cited by 166
Stat3 activation in prostatic carcinomas
Dhir, R., Ni, Z., Lou, W., DeMiguel, F., Grandis, J. R., & Gao, A. C. (2002) · The Prostate · doi:10.1002/pros.10079 · Cited by 136
Kortylewski, M., Heinrich, P. C., Mackiewicz, A. A., Schniertshauer, U., Klingmüller, U., Nakajima, K., Hirano, T., Horn, F., & Behrmann, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202708 · Cited by 135
Molecular causes of colon cancer
Oving, I. M., & Clevers, H. C. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01004.x · Cited by 135
Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells
Ahonen, T. J., Xie, J., LeBaron, M. J., Zhu, J., Nurmi, M. J., Alanen, K. A., Rui, H., & Nevalainen, M. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304307200 · Cited by 132
Smith, P. C., & Keller, E. T. (2001) · The Prostate · doi:10.1002/pros.1080 · Cited by 118
Widschwendter, A., Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., & Doppler, W. (2002) · PubMed · Cited by 107
Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines
Li, L., & Shaw, P. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109962200 · Cited by 102
Modern laser scanning microscopy in biology, biotechnology and medicine
Kj, H., & König, K. (2003) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(03)80002-x · Cited by 102
Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
Angelo, L. S., Talpaz, M., & Kurzrock, R. (2002) · PubMed · Cited by 91
The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common γ-Chain
Lischke, A., Moriggl, R., Brändlein, S., Berchtold, S., Kammer, W., Sebald, W., Groner, B., Liu, X., Hennighausen, L. G., & Friedrich, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31222 · Cited by 78
Self-citationDifferential function of STAT5 isoforms in head and neck cancer growth control
Leong, P. L., Xi, S., Drenning, S. D., Dyer, K. F., Wentzel, A. L., Lerner, E. C., Smithgall, T. E., & Grandis, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205385 · Cited by 72
Homodimerization of Interleukin-4 Receptor α Chain Can Induce Intracellular Signaling
Kammer, W., Lischke, A., Moriggl, R., Groner, B., Ziemiecki, A., Gurniak, C. B., Berg, L. J., & Friedrich, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23634 · Cited by 72
Self-citationHsi, L. C., Angerman‐Stewart, J., & Eling, T. E. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2045 · Cited by 70
Genetic instability in human mismatch repair deficient cancers
Duval, A., & Hamelin, R. (2002) · Annales de Génétique · doi:10.1016/s0003-3995(02)01115-2 · Cited by 69
Vécsey-Semjén, B., Becker, K., Sinski, A., Blennow, E., Vietor, I., Zatloukal, K., Beug, H., Wagner, E., & Huber, L. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205577 · Cited by 60
Self-citationEvaluation of telomerase in the development and progression of colon cancer
Boldrini, L., Faviana, P., Gisfredi, S., Zucconi, Y., Quirico, D. D., Donati, V. L., Berti, P., Spisni, R., Galleri, D., Materazzi, G., et al. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.10.5.589 · Cited by 36
Ma, A., Xia, L. P., Littman, S. J., Swinler, S. E., Lader, G., Polinkovsky, A., Olechnowicz, J., Kasturi, L., Lutterbaugh, J., Modrich, P. L., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203568 · Cited by 30
CELLULAR SIGNALLING PATHWAYS: NEW TARGETS IN LEUKAEMIA THERAPY
Ravandi, F., Talpaz, M., Kantarjian, H. M., & Estrov, Z. E. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03236.x · Cited by 25
Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells
Kirito, K., Nagashima, T., Ozawa, K., & Komatsu, N. (2002) · International Journal of Hematology · doi:10.1007/bf02981979 · Cited by 24
Colorectal cancer screening and follow-up
Fleming, R. (1998) · Surgical Oncology · doi:10.1016/s0960-7404(99)00034-1 · Cited by 16
Norris, A. L., Clissold, P. M., Askham, J. M., Morrison, E. E., Moncur, P. H., McCall, S. H., Coletta, P. L., Meredith, D. M., & Markham, A. F. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00305-6 · Cited by 3
Flagged first, then by citations
6 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 645
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492
Tumor exosomes inhibit differentiation of bone marrow dendritic cells
Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429
Interleukin-6 - A Key Regulator of Colorectal Cancer Development
Waldner, M. J., Foersch, S., & Neurath, M. F. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4614 · Cited by 434
Metadata
- Authors
- Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., Beug, H., Öhlschläger, P., Schütz, A., Halbhuber, K.-J., & Friedrich, K.
- Affiliations
- Friedrich Schiller University Jena (DE)
- Research Institute of Molecular Pathology (AT)
- Georg Speyer Haus (DE)
- Universität Innsbruck (AT)
- University of Graz (AT)
- Leipzig University (DE)
- Corresponding author
- Friedrich, Karlheinz
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 7
- Issue
- 6
- Pages
- 545-555
- ISSN
- 1476-5586 (ISSN-L)
- PMC
- PMC1501283
- OpenAlex
- W2014737409
- Cited by
- 427
- References
- 59
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 27 · 2023: 21 · 2022: 28 · 2021: 40 · 2020: 29 · 2019: 22 · 2018: 15 · 2017: 27 · 2016: 24 · 2015: 30 · 2014: 24 · 2013: 30 · 2012: 17
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neoplasia (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- STAT3, colorectal cancer, constitutive STAT3 activation, interleukin-6, cell proliferation, tumor growth, tumor microenvironment, tumor xenografts, dominant-negative STAT3, therapeutic target, infiltrating lymphocytes
- MeSH terms
- Animals, Biopsy, Cell Differentiation, Colonic Neoplasms, DNA, Genes, Dominant, Humans, Immunohistochemistry, Lymphocytes, Mice, Nude, Neoplasm Transplantation, Retroviridae, Time Factors, Blotting, Western, Colorectal Neoplasms, Signal Transduction, Interleukin-6, Cell Line, Tumor, Cell Proliferation, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
